Vi er bekendt med Danske Regioners ”Fællesregionale principper for efteruddannelse og kompetenceudvikling af regionernes sundhedspersonale”.
Hvis du skal have tilladelse fra f.eks. din afdelingsleder til at deltage, beder vi dig venligst selv sikre dette.
Hvis du ønsker adgang til den fulde invitation som indeholder tilmeldings information, beder vi dig kontakte din afdelingsledelse, som har denne.
Det er med stor fornøjelse, at vi for 10. år i træk har mulighed for at invitere til vores årlige specialistsymposium inden for det respiratoriske område.
Symposiet henvender sig primært til lungemedicinere, yngre læger med interesse for lungemedicin, og alment praktiserende læger med særlig interesse inden for det respiratoriske område.
Symposiet giver dig en god mulighed for at mødes og vidensdele med dine kollegaer.
Vi har igen i år sammensat et spændende program med både danske og internationale foredragsholdere på et højt fagligt niveau.
Teva Danmark ønsker via faglige arrangementer at støtte det respiratoriske område, Astma og KOL-patienter og deres daglige udfordringer.
Med den nødvenlige viden kan vi i fællesskab hjælpe patienterne til at få en bedre hverdag.
Mødet afholdes i samarbejde med Teva Denmark A/S og nyhedsmediet “Medicinsk tidsskrift”.
Det faglige indhold er tilrettelagt og udvalgt af Prof. Vibeke Backer og Prof. Charlotte Suppli Ulrik.
Alle faglige indlæg vil blive afholdt på engelsk.
12.00 - 13.00 FROKOST (for fysisk fremmødte)
13.00 - 14.00 Welcome and introduction by Chairmen Prof. Vibeke Backer and Prof. Charlotte Suppli Ulrik
Our digital future/present
• ”Development of Apps in medicine”
PhD in Biomedical Sciences Sven Seys, Digital & Research Lead
by Galenus Health
• ”The use of Apps in medical disorders seen from the patient’s perspective”
Dr. Eero Punkka, Director of Helsinki Biobank
• ”Apps in medicine – seen from the doctor’s site”
Prof. dr. Peter W. Hellings, University Hospitals Leuven and
Academic Medical Center Amsterdam
14.00 - 14.15 Kaffepause
14.15 - 14.30 “Oral Corticosteroids in Asthma Management”
Reservelæge og ph.d. studerende Inge Raadal Skov, OUH
14.30 - 14.45 The outgoing lung team – a cross-sectorial work for patient with advanced COPD”
Klinisk sygeplejespecialist, Ph.d., Cand. Cur., MLP Birgit Refsgaard,
14.45 - 15.00 “Endoscopic ultrasound in the diagnosis of lung cancer”
Ph.d. studerende og læge Ida Skovgaard Christensen, Næstved
15.00 - 15.15 Kaffepause
15.15 -16.00 ”Post-Covid dyspnea – Next step?”
Prof. PhD Eva Polverino, Hospital Universitari Vall d’Hebron, Barcelona
16.00 - 16.15 Wrap up and thanks
CHARLOTTE SUPPLI ULRIK
Professor MD DMSc FERS. Professor in pulmonary medicine (since 2013, chair professor 2021) and head of the Respiratory Research Unit, Severe Asthma Clinic and Management of Asthma during Pregnancy (MAP) program, Copenhagen University Hospital-Hvidovre. Research focusing on chronic airways diseases asthma, COPD and bronchiectasis) since her years as medical student with a special interest in early detection, management and – not least – outcome. In recent years also with a growing interest in the association between life style factors, including obesity and leisure time activity, and chronic airways diseases.
Professor, Copenhagen University and Pulmonologist with responsibility of Global airways (CRSwNP, asthma and allergy) at department of ENT Rigshospitalet, as well as senior researcher at CFAS, Rigshospitalet, Copenhagen, Denmark Vibeke
Backer has for many years had focus on asthma clinically as well as research wise. With special emphasis on the association between asthma, allergy and hyper responsiveness in populations and later the focus has changed to asthma diagnostics and the relevant tests in order to ensure the right diagnosis for the patients both in research and daily practice. The last decade, increasing interest research wise and clinically in Global airways, with special responsibility of the newer treatment in this area. She has a large research portfolio in sport, exercise, and doping. Furthermore, during the last couple of years the focus of inflammation has been supported by the new biologics for treatment of severe asthma, CRSwNP and COPD. She also has a wide range of publications.
INGE RAADAL SKOV
MD, Ph.D.-student. Department of Respiratory Medicine, Odense University Hospital, Denmark. Inge Raadal Skov is currently working on her Ph.D. project regarding the use of oral corticosteroids in asthma management in Denmark. The major aims
of the project are to investigate real-world trends in oral corticosteroid use during the last two decades, to explore the associated adverse effects and determine the degree of specialist management in a general population of young adults with asthma in Denmark. The pharmacoepidemiological studies are based on ‘real-world data’ from the nationwide Danish registers.
Dr. Ph.d. Eva Polverino has achieved her medical degree in Naples and her specialty and Ph.d. in Respiratory Medicine at the University of Pisa (Italy). After training in research on pathophysiology of respiratory disease she started working in the field
of clinical and translational research in respiratory infections. She developed her major experience in this field as post doctoral investigator at Fundació Clinic of Barcelona. She was associated Professor of the Faculty of medicine (University of Barcelona) between 2014 and 2016 and director of 5 doctoral theses and of an end-of-course project of a medical student. Her main lines of investigation currently are: non cystic fibrosis bronchiectasis (NCFBE), cystic fibrosis (CF); immunodeficiencies and respiratory diseases; Community-acquired pneumonia (CAP) and Health-care associated pneumonia (HCAP).
Sven Seys holds a PhD in Biomedical Sciences and is Research Fellow at KU Leuven (Belgium). At Galenus Health, he coordinates the implementation of a disease management platform in various countries across Europe and is the Research Lead
of a European Outcome Registry on Chronic Rhino- Sinusitis. He has over ten years of experience in pre-clinical, translational and real-life research in the field of chronic respiratory diseases. Previously he was Secretary and Board Member of Asthma
Section (2011-2019) at the European Academy of Allergy and Clinical Immunology and Board Member at the Belgian Society of Allergy and Clinical Immunology (2015-2019).
PETER W. HELLINGS
Peter Hellings graduated magna cum laude from the Katholieke Universiteit Leuven in 1996. He started his specialty training in Otorhinolaryngology in 1996. In 1997, he defended his PhD thesis entitled ‘Immunomodulation in allergic rhinitis and asthma’. In 2003, he performed a clinical and post-doctoral fellowship in Amsterdam, under guidance of Prof. Dr. W. Fokkens. In 2004, he fellow at the Dept. of Otorhinolarynology of the University of Illinois. Since 2004, he is working at the Dept. of Otorhinolaryngology of the University Hospitals Leuven and nominated docent and head docent at the KU Leuven in 2004 and 2008. Appointed full professor at the KU Leuven in 2012. Since 2014, he is nominated full professor at the Academic Medical Center, University of Amsterdam, and nominated guest professor at the University of Ghent in 2015.
Dr. Eero Punkka is currently Director of Helsinki Biobank. Professionally, he has worked in leadership roles of R&D and business development both on the public and private side. He has 20 years of experience in industry ranging from sensor technology
to wellness, health and medical products and services. He has originally a research scientist (physics) background from Helsinki University of Technology, VTT Technical Research Center of Finland and Massachusetts Institute of Technology. His passion lies in the digitalization of healthcare and the utilization of health data for the benefit of patients and health professionals.